Works by Chow, Laura


Results: 28
    1
    2

    First‐In‐Human, First‐In‐Class, Phase I Trial of the Fucosylation Inhibitor SGN‐2FF in Patients with Advanced Solid Tumors.

    Published in:
    Oncologist, 2021, v. 26, n. 11, p. 925, doi. 10.1002/onco.13911
    By:
    • Do, Khanh T.;
    • Chow, Laura Quan Man;
    • Reckamp, Karen;
    • Sanborn, Rachel E.;
    • Burris, Howard;
    • Robert, Francisco;
    • Camidge, D. Ross;
    • Steuer, Conor E.;
    • Strickler, John H.;
    • Weise, Amy;
    • Specht, Jennifer M.;
    • Gutierrez, Martin;
    • Haughney, Peter;
    • Hengel, Shawna;
    • Derleth, Christina Louise;
    • Yap, Timothy A.
    Publication type:
    Article
    3
    4
    5

    Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012.

    Published in:
    2018
    By:
    • Mehra, Ranee;
    • Seiwert, Tanguy Y.;
    • Gupta, Shilpa;
    • Weiss, Jared;
    • Gluck, Iris;
    • Eder, Joseph P.;
    • Burtness, Barbara;
    • Tahara, Makoto;
    • Keam, Bhumsuk;
    • Kang, Hyunseok;
    • Muro, Kei;
    • Geva, Ravit;
    • Chung, Hyun Cheol;
    • Lin, Chia-Chi;
    • Aurora-Garg, Deepti;
    • Ray, Archana;
    • Pathiraja, Kumudu;
    • Cheng, Jonathan;
    • Chow, Laura Q. M.;
    • Haddad, Robert
    Publication type:
    journal article
    6
    7
    8

    A phase I trial to determine the safety, pharmacokinetics, and pharmacodynamics of intercalated BMS-690514 with paclitaxel/carboplatin (PC) in advanced or metastatic solid malignancies.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 5, p. 1273, doi. 10.1007/s00280-013-2126-9
    By:
    • Chow, Laura;
    • Jonker, Derek;
    • Dy, Grace;
    • Nicholas, Garth;
    • Fortin, Catherine;
    • Patricia, Daniel;
    • Adjei, Alex;
    • Belani, Chandra;
    • Gupta, Ashok;
    • Park, Jong-Soon;
    • Zhang, Steven;
    • Sbar, Eric;
    • Laurie, Scott
    Publication type:
    Article
    9

    Sunitinib combined with pemetrexed and cisplatin: results of a phase I dose-escalation and pharmacokinetic study in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer and mesothelioma.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 2, p. 307, doi. 10.1007/s00280-012-2008-6
    By:
    • Camidge, D.;
    • Blais, Normand;
    • Jonker, Derek;
    • Soulières, Denis;
    • Doebele, Robert;
    • Ruiz-Garcia, Ana;
    • Thall, Aron;
    • Zhang, Ke;
    • Laurie, Scott;
    • Chao, Richard;
    • Chow, Laura
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16

    Concurrent cetuximab and postoperative radiation in resected high-risk squamous cell carcinomas of the head and neck: A single-institution experience.

    Published in:
    Head & Neck, 2016, v. 38, n. 9, p. 1318, doi. 10.1002/hed.24437
    By:
    • Araki, Daisuke;
    • Redman, Mary W.;
    • Martins, Renato;
    • Eaton, Keith;
    • Baik, Christina;
    • Chow, Laura;
    • Goulart, Bernardo;
    • Lee, Sylvia;
    • Santana–Davila, Rafael;
    • Liao, Jay;
    • Parvathaneni, Upendra;
    • Laramore, George;
    • Futran, Neal;
    • Mendez, Eduardo;
    • Bhrany, Amit;
    • Rodriguez, Cristina P.
    Publication type:
    Article
    17
    18
    19

    Phase 2 Study of Erlotinib in Combination With Linsitinib (OSI-906) or Placebo in Chemotherapy-Naive Patients With Non-Small-Cell Lung Cancer and Activating Epidermal Growth Factor Receptor Mutations.

    Published in:
    2017
    By:
    • Leighl, Natasha B.;
    • Rizvi, Naiyer A.;
    • de Lima Jr., Lopes Gilberto;
    • Arpornwirat, Wichit;
    • Rudin, Charles M.;
    • Chiappori, Alberto A.;
    • Myung-Ju Ahn;
    • Chow, Laura Q. M.;
    • Bazhenova, Lyudmila;
    • Dechaphunkul, Arunee;
    • Sunpaweravong, Patrapim;
    • Eaton, Keith;
    • Jihong Chen;
    • Medley, Sonja;
    • Poondru, Srinivasu;
    • Singh, Margaret;
    • Steinberg, Joyce;
    • Juergens, Rosalyn A.;
    • Gadgeel, Shirish M.;
    • de Lima, Lopes Gilberto Jr
    Publication type:
    journal article
    20

    Biomarkers predictive of response to pembrolizumab in head and neck cancer.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 6, p. 6603, doi. 10.1002/cam4.5434
    By:
    • Pfister, David G.;
    • Haddad, Robert I.;
    • Worden, Francis P.;
    • Weiss, Jared;
    • Mehra, Ranee;
    • Chow, Laura Q. M.;
    • Liu, Stephen V.;
    • Kang, Hyunseok;
    • Saba, Nabil F.;
    • Wirth, Lori J.;
    • Sukari, Ammar;
    • Massarelli, Erminia;
    • Ayers, Mark;
    • Albright, Andrew;
    • Webber, Andrea L.;
    • Mogg, Robin;
    • Lunceford, Jared;
    • Huang, Lingkang;
    • Cristescu, Razvan;
    • Cheng, Jonathan
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27

    Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans.

    Published in:
    Nature, 2011, v. 477, n. 7362, p. 99, doi. 10.1038/nature10358
    By:
    • Breitbach, Caroline J.;
    • Burke, James;
    • Jonker, Derek;
    • Stephenson, Joe;
    • Haas, Andrew R.;
    • Chow, Laura Q. M.;
    • Nieva, Jorge;
    • Hwang, Tae-Ho;
    • Moon, Anne;
    • Patt, Richard;
    • Pelusio, Adina;
    • Le Boeuf, Fabrice;
    • Burns, Joe;
    • Evgin, Laura;
    • De Silva, Naomi;
    • Cvancic, Sara;
    • Robertson, Terri;
    • Je, Ji-Eun;
    • Lee, Yeon-Sook;
    • Parato, Kelley
    Publication type:
    Article
    28